FR2199973A1 - - Google Patents

Info

Publication number
FR2199973A1
FR2199973A1 FR7333392A FR7333392A FR2199973A1 FR 2199973 A1 FR2199973 A1 FR 2199973A1 FR 7333392 A FR7333392 A FR 7333392A FR 7333392 A FR7333392 A FR 7333392A FR 2199973 A1 FR2199973 A1 FR 2199973A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7333392A
Other languages
French (fr)
Other versions
FR2199973B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of FR2199973A1 publication Critical patent/FR2199973A1/fr
Application granted granted Critical
Publication of FR2199973B1 publication Critical patent/FR2199973B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01—Wetting, emulsifying, dispersing, or stabilizing agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR7333392A 1972-09-20 1973-09-18 Expired FR2199973B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2246013A DE2246013A1 (en) 1972-09-20 1972-09-20 PROCESS FOR THE MANUFACTURING OF POROUS TABLETS

Publications (2)

Publication Number Publication Date
FR2199973A1 true FR2199973A1 (en) 1974-04-19
FR2199973B1 FR2199973B1 (en) 1979-01-05

Family

ID=5856791

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7333392A Expired FR2199973B1 (en) 1972-09-20 1973-09-18

Country Status (9)

Country Link
US (1) US3885026A (en)
JP (1) JPS4969819A (en)
AT (1) AT324568B (en)
CH (1) CH579394A5 (en)
DE (1) DE2246013A1 (en)
FR (1) FR2199973B1 (en)
GB (1) GB1381588A (en)
IT (1) IT998618B (en)
SE (1) SE395366B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366835A1 (en) * 1976-10-06 1978-05-05 Wyeth John & Brother Ltd SHAPED ELEMENT INTENDED TO CONTAIN A CHEMICAL SUBSTANCE, ITS PREPARATION PROCESS AND PACKAGING THE CONTAINER
US4371516A (en) * 1976-10-06 1983-02-01 John Wyeth & Brother Limited Articles for carrying chemicals
WO1993018757A1 (en) * 1992-03-17 1993-09-30 Pfizer Inc. Method of producing porous delivery devices
WO1997028789A1 (en) * 1996-02-09 1997-08-14 Quadrant Holdings Cambridge Ltd. Process to prepare soluble delivery systems using volatile salts
WO2003082247A2 (en) * 2002-03-26 2003-10-09 Teva Pharmaceutical Industries Ltd. Drug microparticles

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078046A (en) * 1975-03-10 1978-03-07 University Of Southern California Process for the catalytic oxidation of carbon monoxide with sulfur dioxide and water
DE2556561C2 (en) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of porous tablets
US4568547A (en) * 1979-08-30 1986-02-04 Herschler R J Solid pharmaceutical compositions comprising MSM and their production
US4883182A (en) * 1985-05-31 1989-11-28 Hughes Raymond J Tamper evident capsule and insert device
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
JP2614409B2 (en) * 1991-12-20 1997-05-28 ファイザー・インコーポレーテッド Porous shaped release formulation and method of making same
DK0620728T3 (en) * 1992-01-13 1997-07-07 Pfizer Preparation of tablets of increased potency
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
AU3570495A (en) 1994-09-22 1996-04-09 Quadrant Holdings Cambridge Limited Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
DE69739967D1 (en) * 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd A rapidly disintegrating tablet in the mouth
KR100481583B1 (en) * 1996-06-14 2005-07-12 교와 핫꼬 고교 가부시끼가이샤 Tablets disintegrate quickly in the oral cavity
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
JP3152664B2 (en) 1996-08-13 2001-04-03 協和醗酵工業株式会社 Isotopic urea tablets
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.
US6376545B1 (en) 1998-11-10 2002-04-23 Teva Pharmaceutical Industries, Ltd. Dispersible compositions containing L-DOPA ethyl ester
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US20030185886A1 (en) * 2000-05-26 2003-10-02 Hanmi Pharm. Co., Ltd. Process for the preparation of rapidly disintegrating tablet
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
GB0028709D0 (en) * 2000-11-24 2001-01-10 S P A Process
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
US20030022912A1 (en) * 2001-02-08 2003-01-30 Martino Alice C. Rapid-onset medicament for treatment of sexual dysfunction
JPWO2002069934A1 (en) * 2001-03-06 2004-07-02 協和醗酵工業株式会社 Oral fast disintegrating preparation
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005514393A (en) 2001-12-19 2005-05-19 ネクター セラピューティクス Supplying aminoglycosides to the lung
EP1545521A2 (en) * 2002-10-04 2005-06-29 Pharmacia Corporation Compositions and methods for treating sexual dysfunction
AU2003284942A1 (en) * 2002-10-30 2004-06-07 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
EP1620075B1 (en) * 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) * 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
DK1804764T3 (en) * 2004-10-28 2008-09-29 Pantec Ag Preparation of a rapidly decaying solid composition from a solid powder and a freeze-drying step
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0516604D0 (en) * 2005-08-12 2005-09-21 Sandoz Ag Rapidly dispersing/disintegrating compositions
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
CN101686942B (en) * 2007-06-27 2012-09-26 韩美药品株式会社 Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
US20090110716A1 (en) * 2007-10-31 2009-04-30 Frank Bunick Orally disintegrative dosage form
CA2767143A1 (en) * 2009-07-06 2011-01-13 Kyorin Pharmaceutical Co., Ltd. Tablet having hollow structure
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8784781B2 (en) * 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
JP5309262B2 (en) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド Fexofenadine microcapsule and composition containing the same
TW201127375A (en) * 2010-01-08 2011-08-16 Eurand Inc Taste masked topiramate composition and an orally disintegrating tablet comprising the same
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
ES2750323T3 (en) 2014-01-10 2020-03-25 Johnson & Johnson Consumer Inc Method for manufacturing a tablet using radio frequency and loss coated particles
MA44720A (en) 2016-04-21 2019-02-27 Astrazeneca Ab ORAL DISINTEGRATION TABLETS
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1742515A (en) * 1924-10-08 1930-01-07 Ambrose J Mandell Method of making porous objects
US2887437A (en) * 1956-08-22 1959-05-19 Pfizer & Co C Palatable vitamin tablet containing an amino acid
US3175521A (en) * 1961-02-23 1965-03-30 Schering Corp Apparatus for punching miniature tablets
US3371984A (en) * 1963-09-06 1968-03-05 Colgate Palmolive Co Air freshener
DE1228029C2 (en) * 1964-05-09 1973-05-17 Merck Ag E Process for the production of tablets by pressing powder mixtures without prior granulation
US3450494A (en) * 1967-07-18 1969-06-17 Conrad J Gaiser Amorphous sodium silicate having inherent binding properties and method of producing same
US3639286A (en) * 1968-05-28 1972-02-01 Mario Ballestra Synthetic detergent in bar or cake form and the method to manufacture same
GB1303102A (en) * 1969-01-16 1973-01-17
US3719599A (en) * 1969-11-25 1973-03-06 Lepetit Spa Solid lubricant composition and method of preparation
LU60170A1 (en) * 1970-01-09 1971-11-18
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
US3739048A (en) * 1971-05-26 1973-06-12 Sumitomo Electric Industries Method of granulating powder
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2366835A1 (en) * 1976-10-06 1978-05-05 Wyeth John & Brother Ltd SHAPED ELEMENT INTENDED TO CONTAIN A CHEMICAL SUBSTANCE, ITS PREPARATION PROCESS AND PACKAGING THE CONTAINER
US4371516A (en) * 1976-10-06 1983-02-01 John Wyeth & Brother Limited Articles for carrying chemicals
WO1993018757A1 (en) * 1992-03-17 1993-09-30 Pfizer Inc. Method of producing porous delivery devices
WO1997028789A1 (en) * 1996-02-09 1997-08-14 Quadrant Holdings Cambridge Ltd. Process to prepare soluble delivery systems using volatile salts
WO2003082247A2 (en) * 2002-03-26 2003-10-09 Teva Pharmaceutical Industries Ltd. Drug microparticles
WO2003082247A3 (en) * 2002-03-26 2004-02-05 Teva Pharma Drug microparticles
EP2085074A1 (en) * 2002-03-26 2009-08-05 Teva Pharmaceutical Industries Ltd. Drug microparticles
EP2085073A1 (en) * 2002-03-26 2009-08-05 Teva Pharmaceutical Industries Ltd. Drug microparticles
EP2085072A1 (en) * 2002-03-26 2009-08-05 Teva Pharmaceutical Industries Ltd. Drug microparticles
EP2087882A1 (en) * 2002-03-26 2009-08-12 Teva Pharmaceutical Industries Ltd. Drug microparticles
US9107832B2 (en) 2002-03-26 2015-08-18 Teva Pharmaceutical Industries, Ltd. Risperidone microparticles formed by sublimation

Also Published As

Publication number Publication date
GB1381588A (en) 1975-01-22
SE395366B (en) 1977-08-15
US3885026A (en) 1975-05-20
IT998618B (en) 1976-02-20
CH579394A5 (en) 1976-09-15
JPS4969819A (en) 1974-07-05
DE2246013A1 (en) 1974-03-28
FR2199973B1 (en) 1979-01-05
AT324568B (en) 1975-09-10

Similar Documents

Publication Publication Date Title
FR2199973B1 (en)
JPS4950537A (en)
JPS4926576U (en)
AU465371B2 (en)
JPS521382B2 (en)
JPS5545139Y2 (en)
JPS5332490Y2 (en)
JPS5227730Y2 (en)
JPS4979848U (en)
JPS5137881Y2 (en)
JPS5011837Y2 (en)
JPS4979940A (en)
JPS4923002A (en)
JPS497982U (en)
CH571483A5 (en)
BG17661A1 (en)
CH576420A5 (en)
CH576425A5 (en)
CH577264A5 (en)
CH577958A5 (en)
CH577989A5 (en)
CH577995A5 (en)
CH578001A5 (en)
CH457473A4 (en)
LU68119A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse